ArticleLeukemia2023

FLT3 inhibitors upregulate CXCR4 and E-selectin ligands via ERK suppression in AML cells and CXCR4/E-selectin inhibition enhances anti-leukemia efficacy of FLT3-targeted therapy in AML.

Yannan Jia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.